SCHEMBL29263294

SCHEMBL29263294

CC1=C(CCCCCCCCCC(=O)O)C(=O)c2ccccc2C1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.54
L3MBTL1 Q9Y468 4/20 0.54
ALDH1A1 P00352 3/20 0.54
LMNA P02545 3/20 0.54
KDM4E B2RXH2 2/20 0.54
HTT P42858 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
APAF1 O14727 1/20 0.54
MITF O75030 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
CDC25B P30305 4/20 0.52
CDC25A P30304 3/20 0.52
MAP2K7 O14733 1/20 0.52
RXFP1 Q9HBX9 1/20 0.51
S100A4 P26447 1/20 0.48
TRAP1 Q12931 1/20 0.46
NPC1 O15118 1/20 0.46
POLB P06746 1/20 0.46
RAB9A P51151 1/20 0.46
F13A1 P00488 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21940525 1.00 MAPT (0.54) MAPTL3MBTL1ALDH1A1LMNAKDM4E
SCHEMBL9709635 1.00 MAPT (0.54) MAPTL3MBTL1ALDH1A1LMNAKDM4E
SCHEMBL30201802 1.00 MAPT (0.54) MAPTL3MBTL1ALDH1A1LMNAKDM4E
SCHEMBL11421782 0.98 MAPT (0.55) MAPTL3MBTL1ALDH1A1LMNAKDM4E
SCHEMBL30005823 0.94 MAPT (0.56) MAPTL3MBTL1ALDH1A1LMNAKDM4E
SCHEMBL4446630 0.94 MAPT (0.56) MAPTL3MBTL1ALDH1A1LMNAKDM4E
SCHEMBL13649357 0.87 MAPT (0.59) MAPTL3MBTL1ALDH1A1LMNAKDM4E
SCHEMBL25753957 0.85 KDM4E (0.46) MAPTL3MBTL1ALDH1A1LMNAKDM4E
SCHEMBL11411263 0.84 MAPT (0.49) MAPTL3MBTL1ALDH1A1LMNAKDM4E
SCHEMBL21878889 0.83 MAPT (0.59) MAPTL3MBTL1ALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400536-A1 IDEBENONE DERIVATIVES AND THEIR USE IN TREATING PLANTS MITORX THERAPEUTICS LTD (GB) 2024-12-05 US disclosed
CN-118234716-A Idebenone derivatives and their use in the treatment of plants 米托克斯治疗有限公司 2024-06-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240400536-A1 IDEBENONE DERIVATIVES AND THEIR USE IN TREATING PLANTS AIFM1, TUFM, SQOR MAPT 2216/4885L3MBTL1 4152/4885ALDH1A1 1104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.